foxo4-dri senolytic peptide 2023 2024 ES2 rapidly destroys TP53-FOXO4 foci leading to TP53 mediated The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



